BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,349,664 | -10.3% | 104,956 | -5.2% | 0.16% | -15.4% |
| Q3 2022 | $5,962,000 | -16.4% | 110,689 | -1.9% | 0.20% | -11.0% |
| Q2 2022 | $7,131,000 | +0.5% | 112,783 | +23.3% | 0.22% | +15.9% |
| Q1 2022 | $7,092,000 | -24.5% | 91,454 | -16.4% | 0.19% | -14.1% |
| Q4 2021 | $9,394,000 | +11.1% | 109,431 | +4.1% | 0.22% | -1.3% |
| Q3 2021 | $8,454,000 | +3.0% | 105,096 | +2.7% | 0.22% | -1.8% |
| Q2 2021 | $8,207,000 | -1.5% | 102,352 | +3.6% | 0.23% | -13.7% |
| Q1 2021 | $8,333,000 | -12.0% | 98,807 | -16.3% | 0.26% | -22.6% |
| Q4 2020 | $9,468,000 | +2.5% | 117,992 | +2.7% | 0.34% | -12.6% |
| Q3 2020 | $9,239,000 | -22.8% | 114,886 | -17.4% | 0.39% | -24.0% |
| Q2 2020 | $11,972,000 | +23.6% | 139,054 | +16.5% | 0.51% | +0.6% |
| Q1 2020 | $9,690,000 | +16.9% | 119,359 | +20.4% | 0.51% | +37.9% |
| Q4 2019 | $8,290,000 | -8.6% | 99,133 | -4.4% | 0.37% | -13.0% |
| Q3 2019 | $9,071,000 | +7.1% | 103,707 | +0.3% | 0.42% | +3.7% |
| Q2 2019 | $8,471,000 | +2.0% | 103,435 | +1.3% | 0.41% | -2.6% |
| Q1 2019 | $8,302,000 | +25.9% | 102,100 | +1.9% | 0.42% | +10.2% |
| Q4 2018 | $6,594,000 | +0.2% | 100,181 | +17.4% | 0.38% | +15.8% |
| Q3 2018 | $6,578,000 | +20.9% | 85,325 | +15.7% | 0.33% | +13.1% |
| Q2 2018 | $5,443,000 | +1529.6% | 73,718 | +1336.7% | 0.29% | +1516.7% |
| Q1 2018 | $334,000 | +7.1% | 5,131 | +6.4% | 0.02% | +5.9% |
| Q4 2017 | $312,000 | +3.0% | 4,821 | 0.0% | 0.02% | 0.0% |
| Q3 2017 | $303,000 | -81.6% | 4,821 | -86.1% | 0.02% | -84.0% |
| Q3 2016 | $1,648,000 | +4.9% | 34,620 | -0.4% | 0.11% | +1.9% |
| Q2 2016 | $1,571,000 | +445.5% | 34,749 | +395.0% | 0.10% | +447.4% |
| Q1 2016 | $288,000 | +8.7% | 7,020 | +1.1% | 0.02% | +5.6% |
| Q4 2015 | $265,000 | -84.9% | 6,943 | -85.0% | 0.02% | -84.1% |
| Q2 2015 | $1,756,000 | -45.7% | 46,213 | -2.1% | 0.11% | -46.2% |
| Q1 2015 | $3,233,000 | -68.6% | 47,190 | -66.4% | 0.21% | -70.0% |
| Q4 2014 | $10,302,000 | -0.9% | 140,565 | -3.0% | 0.70% | -22.1% |
| Q3 2014 | $10,398,000 | +44.4% | 144,877 | +45.5% | 0.90% | +45.7% |
| Q2 2014 | $7,200,000 | -3.0% | 99,588 | -1.2% | 0.62% | -11.6% |
| Q1 2014 | $7,420,000 | +2.1% | 100,839 | -3.5% | 0.70% | -2.2% |
| Q4 2013 | $7,267,000 | -17.0% | 104,492 | -21.6% | 0.71% | -26.8% |
| Q3 2013 | $8,751,000 | -38.3% | 133,212 | -34.9% | 0.98% | -44.3% |
| Q2 2013 | $14,183,000 | – | 204,741 | – | 1.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |